Acuitas Therapeutics Highlights In Vivo CAR T Cell Engineering and Ionizable Lipid Quality Attributes at the 2026 ASGCT Annual Meeting
Read
about Acuitas Therapeutics Highlights In Vivo CAR T Cell Engineering and Ionizable Lipid Quality Attributes at the 2026 ASGCT Annual Meeting
Acuitas Therapeutics Announces Four Scientific Presentations at the 2026 ASGCT Annual Meeting
Read
about Acuitas Therapeutics Announces Four Scientific Presentations at the 2026 ASGCT Annual Meeting
Acuitas Therapeutics To Present at the 2026 Bloom Burton & Co. Healthcare Investor Conference
Read
about Acuitas Therapeutics To Present at the 2026 Bloom Burton & Co. Healthcare Investor Conference
Acuitas Therapeutics Named Canada’s Top Small and Medium Employers in 2026
Read
about Acuitas Therapeutics Named Canada’s Top Small and Medium Employers in 2026
Acuitas Therapeutics’ Lipid Nanoparticle Technology Supports Positive Phase I Data Published by AstraZeneca
Read
about Acuitas Therapeutics’ Lipid Nanoparticle Technology Supports Positive Phase I Data Published by AstraZeneca
Acuitas Therapeutics Named Top 100 Global Innovator by LexisNexis for 2026
Read
about Acuitas Therapeutics Named Top 100 Global Innovator by LexisNexis for 2026
Acuitas Therapeutics Announces Oral Presentations and Poster Sessions at BioChina and Vaccine Innovation Forum
Read
about Acuitas Therapeutics Announces Oral Presentations and Poster Sessions at BioChina and Vaccine Innovation Forum
Acuitas Therapeutics Named One of BC’s Top Employers
Read
about Acuitas Therapeutics Named One of BC’s Top Employers
Dr. Ying Tam and Sean Semple Share the New Frontier of Lipid Nanoparticles in mRNA Cancer Vaccines in the European Biopharmaceutical Review
Read
about Dr. Ying Tam and Sean Semple Share the New Frontier of Lipid Nanoparticles in mRNA Cancer Vaccines in the European Biopharmaceutical Review
Acuitas Therapeutics Expands Collaboration with RNA Technologies & Therapeutics Through Strategic Investment
Read
about Acuitas Therapeutics Expands Collaboration with RNA Technologies & Therapeutics Through Strategic Investment